Clinical Trials and Research

At the core of what we do is make sure that we give you the best chance for the best outcome. That means pushing the scientific boundaries of our cancer knowledge and leaving no stone unturned when it comes to new and innovative therapies.
Researcher at the Center for Cancer Research.
Researcher at the Center for Cancer Research.
Researcher at the Center for Cancer Research.

Progress in Targeted Cancer Care

Eradicating cancer takes commitment and creativity. We have both. Commitment to explore novel combinations of therapies. Creativity to collaborate, apply learnings, and advance treatment options.

Leapfrog Moments in Cancer Therapies with Keith Flaherty, MD

With so many new cancer treatments in development and now available, cancer care is fundamentally different than it was just a few years ago. Go behind the scenes with our Director of Clinical Research, Dr. Keith Flaherty, to learn how teams of researchers and clinicians are applying scientific insights to propel the creation of new therapies for patients.

Progress in Immunotherapy

The Mass General Cancer is proud to be an authorized treatment center for two FDA approved CAR T-cell therapies for adult patients with lymphoma. Where, before, patients were given little or no hope, now there is real and meaningful scientific progress. Today it's lymphoma and CAR-T therapy. Tomorrow? We think big so you can dream big.

Progress in Early Cancer Detection

Clinical Trials and Research

Our commitment to eradicating cancer is fueled by scientific investigation as part of the largest hospital-based research program in the United States.